A GOSH-led trial found that replacing intensive chemotherapy with blinatumomab in relapsed childhood ALL eliminated treatment-related deaths while maintaining survival rates.
Press Association
Source link : https://www.medscape.com/s/viewarticle/kinder-chemo-approach-boosts-survival-child-all-2026a1000dv5?src=rss
Author :
Publish date : 2026-04-30 19:43:00
Copyright for syndicated content belongs to the linked Source.